Ananda Pharma Plc — Director's Dealing 2024

Nov 12, 2024

National Storage Mechanism | Additional information

RNS Number : 7909L

Ananda Developments PLC

12 November 2024

12 November 2024

ANANDA DEVELOPMENTS PLC  

("Ananda" or the "Company")  

Director Dealing

Ananda Developments plc (AQSE: ANA) announces that Melissa Sturgess, Chief Executive Officer of the Company, has purchased a total of 2,015,166 ordinary shares of 0.2 pence each in the Company ("Ordinary Shares") via four transactions at a weighted average price of 0.32 pence per Ordinary Share. The Ordinary Shares were purchased on market.

Following this transaction, Melissa Sturgess is beneficially interested in 422,382,284 Ordinary Shares, representing 9.92 of the total issued share capital of the Company.

-Ends-

To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are:  

·    Investor Hub: investors.anandadevelopments.com

·     Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=       

·     LinkedIn : https://www.linkedin.com/company/anadevelopments/       

·    Twitter : https://twitter.com/AnandaPlc

·     Investor Meet Company: https://www.investormeetcompany.com/ananda-developments-plc/register-investor

-Ends-  

The Directors of the Company accept responsibility for the contents of this announcement.  

ANANDA DEVELOPMENTS PLC	+44 (0)7463 686 497
	[email protected]
Chief Executive Officer
Melissa Sturgess
Finance Director
Jeremy Sturgess-Smith
SP ANGEL CORPORATE FINANCE LLP	+44 (0)20 3470 0470
Corporate Finance
Richard Morrison
Caroline Rowe
Corporate Broking
Abigail Wayne
Rob Rees
Yellow Jersey PR (media enquiries) Sarah MacLeod Charles Goodwin Zara McKinlay	+44 (0)20 3004 9512 [email protected]

About Ananda Developments  

Ananda is an AQSE-listed life sciences company focused on the research and clinical development of CBD-based therapies for a range of complex inflammatory pain conditions.

For more information, please visit: https://anandadevelopments.com

https://investors.anandadevelopments.com/link/8r6x4y

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Melissa Sturgess

2

Reason for the notification

a)

Position/status

CEO

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor

a)

Name

Ananda Developments plc

b)

LEI

894500DFM8VOC5FW4X47

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 0.2p each

ISIN: GB00BDQPXQ60

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Date	Price (p)	Volume
6.11.24	0.33	152,439
5.11.24	0.33	303,353
1.11.24	0.32	623,437
31.10.24	0.32	935,937

d)

Aggregated information

- Aggregated volume

- Price

2,015,666 Ordinary Shares

VWAP of 0.32 per Ordinary Share

e)

Date of the transaction

31-October 2024 to 6 November 2024

f)

Place of the transaction

AQSE

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXVFLFFZFLEFBD